OncoCyte Corp (OCX) Financials

$2.83

$-0.33 (-10.44%)

As on 17-Jul-2025 09:30EDT

Market cap

$92 Mln

Revenue (TTM)

$4 Mln

P/E Ratio

--

P/B Ratio

7.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	3.84	1.88	1.50	0.96	7.73	1.22
Cost of Revenue	1.44	1.14	1.09	0.98	7.54	1.86
Gross Profit	2.02	0.74	0.41	-0.02	0.19	-0.64
Operating Expenses	60.81	60.64	25.64	30.31	47.13	33.08
Operating Profit (EBIT)	-58.57	-61.04	-25.14	-18.00	-46.95	-29.71
Other Income	--	--	--	-0.54	1.06	-1.22
Profit before Tax	-58.21	-60.66	-24.86	-18.61	-73.36	-31.19
Provision for Tax	--	--	2.93	54.83	-9.26	-1.25
Profit after Tax (Net Income)	-58.21	-60.66	-27.78	-73.44	-64.10	-29.93
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-73.42	-64.10	-29.93

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	10.22	-12.27	25.59	34.29	65.22	33.48
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	40.46	40.08	42.10	53.69	80.23	12.94
Current Liabilities	9.68	7.28	7.19	12.11	14.12	9.00
Total Liabilities	70.04	35.08	74.89	100.09	159.56	55.42

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	24.10	23.32	64.19	74.56	120.42	46.19
Current Assets	36.26	11.76	10.70	25.54	39.14	9.23
Total Assets	70.04	35.08	74.89	100.09	159.56	55.42
Total Debt*	3.48	3.66	2.87	3.54	5.68	8.63
Net Current Assets	26.58	4.48	3.50	13.43	25.02	0.23

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-20.71	-23.33	-45.57	-35.94	-25.98
Cash Flow from Investing Activities	--	--	--	-4.34	-13.96	-11.75
Cash from Financing Activities	--	20.43	12.19	35.81	78.36	22.80
Net Cash Inflow / Outflow	--	--	--	-14.10	28.46	-14.93

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-611.12	-83.81	-135.09	-113.44	-75.88
ROE (%)	-584.12	-910.86	-92.78	-147.60	-129.88	-93.07
ROA (%)	-77.95	-110.32	-31.75	-56.57	-59.63	-62.83
EBIT Margin (%)	-1,349.41	-3,220.57	-1,650.23	-1,934.76	-681.53	-2,543.91
Net Margin (%)	-1,514.57	-3,225.04	-1,848.37	-17,485.71	-729.20	427,600.00
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	178.08	0.25	0.57	-0.88	5.35	75.00
EBIT Growth (%)	-157.26	-144.24	-33.82	64.80	-70.24	-39.10
Net Profit Growth (%)	-45.72	-118.36	62.17	-14.58	-114.14	-34.05
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	--	--	--	--	--
Price / Book Value	7.92	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.25	0.08	0.28	1.27	0.64	-0.03
Close Price ($)	3.06	2.38	2.50	6.42	43.40	47.80
High Price ($)	4.75	3.82	10.00	45.28	131.40	70.20
Low Price ($)	1.92	1.97	2.08	4.84	40.30	23.00
Market Cap ($ Cr)	91.52	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	-0.30	0.11	0.10	0.09	0.26
Short term debt to equity ratio	0.14	-0.11	0.03	0.05	0.05	0.10
Current Ratio	3.75	1.62	1.49	2.11	2.77	1.03
Quick Ratio	3.70	1.56	1.49	1.93	2.75	1.03
Interest Coverage	-592.93	-721.18	-476.98	-223.31	-251.97	-122.75

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	92.12	85.75	32.20	210.02	18.60	16.69
Asset Turnover	0.05	0.03	0.02	0.01	0.07	0.03
Receivable days	--	203.60	303.28	657.49	38.76	60.98
Inventory Days	--	65.62	355.36	453.76	7.36	--
Payable days	--	517.30	369.61	573.14	54.31	88.70
Cash Conversion Cycle	--	-248.08	289.04	538.11	-8.19	-27.73

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.